Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.24.1.1.u2
Stock Based Compensation (Details)
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Stock Based Compensation  
Number of shares, Beginning balance | shares 17,037,500
Number of shares, Grants | shares 1,000,000
Number of shares, Exercised | shares (18,750)
Number of shares, Ending balance | shares 18,018,750
Options exercisable, Ending balance | shares 17,956,250
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.53
Weighted Average Exercise Price, Grants | $ / shares 0.88
Weighted Average Exercise Price, Exercised | $ / shares 0.27
Weighted Average Exercise Price, Ending balance | $ / shares 0.55
Weighted Average Exercise Price exercisable, Ending balance | $ / shares $ 0.55
Weighted Average Remaining Contractual Life (years), Beginning balance 1 year 5 months 19 days
Weighted Average Remaining Contractual Life (years), Ending balance 1 year 5 months 1 day
Weighted Average Remaining Contractual Life exercisable, Ending balance 1 year 4 months 28 days
Aggregate Intrinsic Value, Beginning balance | $ $ 6,970,750
Aggregate Intrinsic Value, Ending balance | $ 8,155,625
Options exercisable, Ending balance, Intrinsic value | $ $ 8,119,375